Wikipedia:Articles for deletion/Rajinder Kumar Kamboj
Lupin is http://www.lupinpharmaceuticals.com/about.htm a US$ 694 million pharmaceutical company; barely above midsized by American/global standards. By comparison, Merck’s sales are US$ 23 billion (Pfizer=$48B, Johnson&Johson=$63B). As a company representative, the subject’s http://news.google.com/archivesearch?as_q=kamboj+lupin news coverage is fairly limited, which I think is important to check because even small companies can generate a lot of media coverage. So I think that notability here has to be established based on  criteria. I think that this http://scholar.google.com/scholar?as_sauthors=%22RK+Kamboj%22 citation impact may not be enough, since in the most widely cited papers he is neither the last or first author. I don’t think patents are a good basis for -notability assessment
— User:Eric, 01:34, 12 March 2009 (UTC)
Stance: delete
Cited policy: WP:PROF||WP:PROF (Wikipedia:Notability)